add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Chest pain patients missed by ED6minutes - - Nov 26, 2009 They found that 28% of the discharged patients had signs of acute coronary syndrome such as troponin levels or ECG changes evident at discharge and which ... Randomised Dabigatran Etexilate Dose Finding Study in Patients With Acute ...Cardiosource - - Nov 18, 2009 ... was to compare various dosages of the oral direct thrombin inhibitor dabigatran compared with placebo among patients after an acute coronary syndrome. ... Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patientsPR Newswire (press release) - Nov 18, 2009 The presentation was entitled "Viral Anti-inflammatory Treatment of Unstable Coronary Syndromes: The VT-111 Acute Coronary Syndrome Trial". ... Coronary Computed Tomography for Systemic Triage of Acute Chest Pain Patients ...Cardiosource - - Nov 18, 2009 The proportion of patients who had a final diagnosis of acute coronary syndrome was 3.2% versus 3.0% (p = NS). In the coronary CT angiography group, ... Newer Blood Thinners May Outperform Old StandbysU.S. News & World Report - - Nov 18, 2009 The trial involved more than 18000 patients in 24 countries with acute coronary syndrome who were randomized to receive one of four doses of dabigatran, ... Patient enrollment completed for first of two Phase 3 trials for SCH 530348 ...Monthly Prescribing Reference - Nov 13, 2009 The second trial, Phase 3 Thrombin Receptor Antagonist Clinical Event Reduction in acute coronary syndrome (TRA-CER), is a randomized, double-blind, ... Merck enrolls patients in late-stage trial for heart attack-preventing drug Drug Store News (blog) Cost effective heart drug listed on PBSPharmacy News - - Nov 24, 2009 Australia's 34000 Acute Coronary Syndrome (ACS) patients will have access to a new antiplatelet therapy from the 1st December when it becomes available on ... AstraZeneca Drug Beats Plavix for Myocardial InfarctioneMaxHealth - - Nov 15, 2009 ... in treating heart patients who have the most serious type of acute coronary syndrome, those with ST segment elevation myocardial infarction (STEMI). ... Video: Ticagrelor (BRILINTA(TM)) Demonstrated Greater Efficacy Over ... PR Newswire (press release) AstraZeneca Applies To the FDA For Its New Angina and Heart Attack TreatmentProactive Investors UK - Nov 19, 2009 The application is for an investigational oral antiplatelet treatment for patients with acute coronary syndrome (ACS). The proposed trade name for ... Results From Two Phase II Trials Add to Understanding of Ticagrelor (BRILINTA ... PR Newswire (press release) BioMed News Bytes: AstraZeneca, Delcath, Unilife Seeking Alpha (blog) Studies give AstraZeneca blood clot drug boost over competitor The News Journal Nanosphere Announces FDA Submission of 510(k) Documentation for Its Verigene ...CNNMoney.com (press release) - Nov 18, 2009 ... a critical test to aid in the diagnosis and treatment of myocardial infarction and in the risk stratification of patients with acute coronary syndrome. ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
